XQQI Short Volume

NEOS Boosted Nasdaq-100 High Income ETF (XQQI) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $8.6M, listed on NASDAQ, carrying a beta of 0.00 to the broader market. The NEOS Boosted Nasdaq-100 High Income ETF (the “Fund”) seeks to boost performance by generating high monthly income in a tax efficient manner with the potential for enhanced equity appreciation in rising markets. Led by Jonathan Thomas, public since 2026-02-03.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-06-01
Short Volume
336.8K
Total Volume
436.1K
Short %
77.22%
30-Day Avg Short %
57.64%

Showing 30 days of FINRA short volume data for NEOS Boosted Nasdaq-100 High Income ETF.

Learn how short volume is reported and how to read the data →

Frequently asked XQQI short volume questions

What is the daily XQQI short volume?
As of Jun 1, 2026, NEOS Boosted Nasdaq-100 High Income ETF (XQQI) short volume is 336.8K shares against 436.1K total reported volume, or 77.22% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is XQQI short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does XQQI short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.